What is the growth rate for the MicroRNA Market over the forecast period?

The global MicroRNA Market is one of the lucrative growth markets, poised to register a 14.4 growth (CAGR) between 2024 and 2032.

Which Markets Offer the Most Lucrative Opportunities in the Industry?

Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.

What is the period of study of the MicroRNA Market?

Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume

MicroRNA Market Size, Share, Trends, Growth Outlook

Home
Growth Reports
|Published Month : October, 2024
|No. of Pages : 200

Overview
Table of Contents
Segmentation
Sample Request

MicroRNA Market is estimated to increase at a growth rate of 14.4% CAGR over the forecast period from 2024 to 2032.

The MicroRNA Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Services Type (Isolation & Purification, miRNA cDNA Synthesis, Profiling, Localization, & Quantification, Functional Analysis, Others), By Specimen Type (Whole Blood, Serum, Plasma, FFPE, Fresh Frozen Tissue, Others), By Instruments (Technology, -Real Time PCR, -Microarray, -NGS, Workflow, -Isolation & Purification, -miRNA cDNA Synthesis, -Profiling, Localization, & Quantification, -Functional Analysis, Others), By Consumables (Specimens, -Whole Blood, -Serum, -Plasma, -FFPE, -Fresh Frozen Tissue, Workflow, -Isolation & Purification, -miRNA cDNA Synthesis, -Profiling, Localization, & Quantification, -Functional Analysis), By Application (Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others), By End-user (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Others).

An Introduction to MicroRNA Market in 2024

The MicroRNA Market is witnessing robust growth, driven by the increasing understanding of microRNA's role in gene regulation and its potential as diagnostic and therapeutic targets. MicroRNAs are small RNA molecules that play a crucial role in controlling gene expression. This market encompasses technologies and products for the detection, profiling, and modulation of microRNAs for various applications, including cancer diagnosis, cardiovascular disease research, and drug development. Manufacturers are developing innovative tools such as microRNA assays and inhibitors to support research and clinical applications. With the growing focus on personalized medicine and biomarker discovery, the MicroRNA Market is poised for continuous expansion, contributing to advancements in molecular diagnostics and targeted therapies.

Market Trend: Growing Emphasis on MicroRNA Biomarkers in Disease Diagnosis and Prognosis

The most prominent trend in the MicroRNA Market is the growing emphasis on microRNA (miRNA) biomarkers in disease diagnosis and prognosis. MicroRNAs play a crucial role in regulating gene expression and have been identified as potential biomarkers for various diseases, including cancer, cardiovascular disorders, and neurological conditions. This trend involves extensive research and development efforts to identify specific miRNA signatures associated with different diseases, paving the way for the development of diagnostic tests and prognostic tools. The MicroRNA Market is witnessing a shift towards personalized medicine with the use of miRNA biomarkers to improve early detection, stratification of patient populations, and monitoring of disease progression.

Market Driver: Increased Understanding of MicroRNA Functions and Therapeutic Potential

A major driver propelling the MicroRNA Market is the increased understanding of microRNA functions and their therapeutic potential. Advances in genomics and molecular biology have deepened our understanding of the role of miRNAs in various biological processes and disease pathways. This driver is fueling research into the therapeutic modulation of miRNAs for the treatment of diseases. The development of miRNA-based therapeutics, including miRNA mimics and inhibitors, holds promise for addressing unmet medical needs. The driver towards harnessing the therapeutic potential of miRNAs is contributing to the expansion of the MicroRNA Market, with ongoing clinical trials and innovative approaches aimed at leveraging the unique regulatory roles of miRNAs in disease management.

Potential Opportunity: Development of miRNA-Based Diagnostics and Therapeutics

An emerging opportunity in the MicroRNA Market lies in the development of miRNA-based diagnostics and therapeutics. Market players have the potential to capitalize on the expanding knowledge of miRNA involvement in diseases by creating innovative diagnostic tools for early disease detection and progression monitoring. Additionally, the opportunity involves advancing miRNA-based therapeutics as a new class of drugs, including the development of miRNA-targeted therapies for conditions where conventional treatments may be limited. Seizing this opportunity allows companies to contribute to the evolution of precision medicine by leveraging the unique characteristics of miRNAs for diagnostic and therapeutic purposes, potentially revolutionizing how certain diseases are diagnosed and treated.

MicroRNA Market Segmentation

By Services Type

Isolation & Purification
miRNA cDNA Synthesis
Profiling, Localization, & Quantification
Functional Analysis
Others

By Specimen Type

Whole Blood
Serum
Plasma
FFPE
Fresh Frozen Tissue
Others

By Instruments

Technology
Real Time PCR
Microarray
NGS
Others
Workflow
Isolation & Purification
miRNA cDNA Synthesis
Profiling, Localization, & Quantification
Functional Analysis & Others
Others

By Consumables

Specimens
Whole Blood
Serum
Plasma
FFPE
Fresh Frozen Tissue
Others
Workflow
Isolation & Purification
miRNA cDNA Synthesis
Profiling, Localization, & Quantification
Functional Analysis
Others

By Application

Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others

By End-User

Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Others

By Region

North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Others)
Asia Pacific (China, India, Japan, South Korea, Australia, Others)
Latin America (Brazil, Argentina, Others)
Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

MicroRNA Market Companies

Thermo Fisher Scientific, Inc.
QIAGEN
Horizon Discovery Group plc.
NanoString Technologies, Inc.
Merck KGaA
Takara Bio, Inc.
LGC Limited
BioGenex
GeneCopoeia, Inc.
New England Biolabs

Reasons to Buy the MicroRNA Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the MicroRNA Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the MicroRNA Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 INTRODUCTION TO 2024 MicroRNA Markets
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 RESEARCH METHODOLOGY
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 EXECUTIVE SUMMARY
3.1 Global MicroRNA Market Size Outlook, $ Million, 2021 to 2030
3.2 MicroRNA Market Outlook by Type, $ Million, 2021 to 2030
3.3 MicroRNA Market Outlook by Product, $ Million, 2021 to 2030
3.4 MicroRNA Market Outlook by Application, $ Million, 2021 to 2030
3.5 MicroRNA Market Outlook by Key Countries, $ Million, 2021 to 2030

4 MARKET DYNAMICS
4.1 Key Driving Forces of MicroRNA Market Industry
4.2 Key Market Trends in MicroRNA Market Industry
4.3 Potential Opportunities in MicroRNA Market Industry
4.4 Key Challenges in MicroRNA Market Industry
5 MARKET FACTOR ANALYSIS
5.1 Competitive Landscape
5.1.1 Global MicroRNA Market Share by Company
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 GROWTH OUTLOOK ACROSS SCENARIOS
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 GLOBAL MicroRNA Market OUTLOOK BY SEGMENTS
7.1 MicroRNA Market Outlook by Segments
By Services Type
Isolation & Purification
miRNA cDNA Synthesis
Profiling, Localization, & Quantification
Functional Analysis
Others

By Specimen Type
Whole Blood
Serum
Plasma
FFPE
Fresh Frozen Tissue
Others

By Instruments
Technology
-Real Time PCR
-Microarray
-NGS
-Others
Workflow
-Isolation & Purification
-miRNA cDNA Synthesis
-Profiling, Localization, & Quantification
-Functional Analysis & Others
-Others
By Consumables
Specimens
-Whole Blood
-Serum
-Plasma
-FFPE
-Fresh Frozen Tissue
-Others
Workflow
-Isolation & Purification
-miRNA cDNA Synthesis
-Profiling, Localization, & Quantification
-Functional Analysis
-Others